CONCENTRIX CORPORATION (CNXC) FY2026 Q3 Balance Sheet

Balance Sheet

As of 2026-08-31

Swipe to see the full flow
CONCENTRIX CORPORATION (CNXC) FY2026 Q3 Balance SheetBalance sheet as of 2026-08-31. The chart shows assets, liabilities and equity at that date.Current liabilities$2.37 BCurrent assets$2.92 BLiabilities$7.49 BAssets$9.26 BNon-current liabilities$5.12 BNon-current assets$6.34 BEquity$1.77 BGross equity(calculated)$3.86 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSAccounts receivable, netOther current assetsCash and cash equivalentsAssets held for saleGoodwillIntangible assets, netOperating lease ROU assetsProperty and equipment, netDeferred tax assetsOther assetsOther accrued liabilitiesAccrued compensation and benefitsCurrent portion of long-term debtAccounts payableLiabilities held for saleIncome taxes payableLong-term debt, netOther long-term liabilitiesDeferred tax liabilitiesAdditional paid-in capitalCommon stock, $0.0001 par value, 250,000 shares authorized; 70,679 and 70,316 shares issued as of August 31, 2026 and November 30, 2025, respectively, and 60,948 and 61,739 shares outstanding as of August 31, 2026 and November 30, 2025, respectivelyCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Retained deficitTreasury stock, 9,731 and 8,577 shares as of August 31, 2026 and November 30, 2025, respectivelyAccumulated other comprehensive lossOther accrued liabilitiesOther accrued liabilities$763.41 MCurrent liabilitiesCurrent liabilities$2.37 BAccrued compensation and benefitsAccrued compensation and benefits$680.04 MCurrent assetsCurrent assets$2.92 BAccounts receivable, netAccounts receivable, net$1.97 BCurrent portion of long-term debtCurrent portion of long-term debt$450.00 MLiabilitiesLiabilities$7.49 BAccounts payableAccounts payable$221.50 MOther current assetsOther current assets$489.24 MAssetsAssets$9.26 BLiabilities held for saleLiabilities held for sale$182.15 MCash and cash equivalentsCash and cash equivalents$244.69 MIncome taxes payableIncome taxes payable$73.22 MAssets held for saleAssets held for sale$212.96 MNon-current liabilitiesNon-current liabilities$5.12 BNon-current assetsNon-current assets$6.34 BGoodwillGoodwill$2.64 BLong-term debt, netLong-term debt, net$3.93 BIntangible assets, netIntangible assets, net$1.65 BOther long-term liabilitiesOther long-term liabilities$949.87 MEquityEquity$1.77 BOperating lease ROU assetsOperating lease ROU assets$864.75 MDeferred tax liabilitiesDeferred tax liabilities$246.48 MGross equity (calculated)Gross equity(calculated)$3.86 BProperty and equipment, netProperty and equipment, net$698.12 MDeferred tax assetsDeferred tax assets$346.06 MAdditional paid-in capitalAdditional paid-in capital$3.86 BOther assetsOther assets$147.04 MCommon stock, $0.0001 par value, 250,000 shares authorized; 70,679 and 70,316 shares issued as of August 31, 2026 and November 30, 2025, respectively, and 60,948 and 61,739 shares outstanding as of August 31, 2026 and November 30, 2025, respectivelyCommon stock$7.00 KRetained deficitRetained deficit−$1.16 BTreasury stock, 9,731 and 8,577 shares as of August 31, 2026 and November 30, 2025, respectivelyTreasury stock−$657.42 MAccumulated other comprehensive lossAccumulated other comprehensive loss−$275.90 M
Chart details

CONCENTRIX CORPORATION (CNXC) FY2026 Q3 Balance Sheet

Balance sheet as of 2026-08-31. The chart shows assets, liabilities and equity at that date.

Assets
9,260,769,000 US dollars
Current assets
2,916,737,000 US dollars
Non-current assets
6,344,032,000 US dollars
Liabilities
7,492,030,000 US dollars
Current liabilities
2,370,314,000 US dollars
Non-current liabilities
5,121,716,000 US dollars
Equity
1,768,739,000 US dollars
Accounts receivable, net
1,969,848,000 US dollars
Other current assets
489,238,000 US dollars
Cash and cash equivalents
244,692,000 US dollars
Assets held for sale
212,959,000 US dollars
Goodwill
2,636,667,000 US dollars
Intangible assets, net
1,651,400,000 US dollars
Operating lease ROU assets
864,749,000 US dollars
Property and equipment, net
698,116,000 US dollars
Deferred tax assets
346,058,000 US dollars
Other assets
147,042,000 US dollars
Other accrued liabilities
763,409,000 US dollars
Accrued compensation and benefits
680,040,000 US dollars
Current portion of long-term debt
450,000,000 US dollars
Accounts payable
221,495,000 US dollars
Liabilities held for sale
182,149,000 US dollars
Income taxes payable
73,221,000 US dollars
Long-term debt, net
3,925,373,000 US dollars
Other long-term liabilities
949,867,000 US dollars
Deferred tax liabilities
246,476,000 US dollars
Additional paid-in capital
3,859,842,000 US dollars
Common stock, $0.0001 par value, 250,000 shares authorized; 70,679 and 70,316 shares issued as of August 31, 2026 and November 30, 2025, respectively, and 60,948 and 61,739 shares outstanding as of August 31, 2026 and November 30, 2025, respectively
7,000 US dollars
Preferred stock, $0.0001 par value, 10,000 shares authorized and no shares issued and outstanding as of August 31, 2026 and November 30, 2025, respectively
0 US dollars
Retained deficit
negative 1,157,782,000 US dollars
Treasury stock, 9,731 and 8,577 shares as of August 31, 2026 and November 30, 2025, respectively
negative 657,424,000 US dollars
Accumulated other comprehensive loss
negative 275,904,000 US dollars
Gross equity (calculated)
3,859,849,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
CONCENTRIX CORPORATION (CNXC) FY2026 Q3 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!